Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: August 2015
-
By Donald Zuhn — Last month, in a letter to Congressional leadership, 79 Members of Congress expressed their support for the Innovation Act (H.R. 9) but sought inclusion of language in the bill "to preserve the integrity of the Drug Price Competition and Patent Term Restoration Act (commonly known as Hatch-Waxman), and the Biologics Price…
-
By Andrew Williams — Earlier this week, we noted that parties wishing to challenge IPR Final Written Decisions from the PTAB on appeal to the Federal Circuit would face an uphill challenge. However, even if that challenge is extremely difficult, it is not necessarily futile. This was demonstrated by the Federal Circuit on June 16,…
-
By Kevin E. Noonan — Last week, Rep. Bob Goodlatte, Chairman of the House Judiciary Committee, released a 200-page Report on H.R. 9, "The innovation Act," introduced by Chairman Goodlatte with several co-sponsors earlier this year. The bill sets forth several "reforms" of U.S. patent law, primarily directed to addressing the "problem" of so-called "patent…
-
By Andrew Williams — One of the first IPR petitions ever filed, IPR2012-0006, was related to biotechnology — specifically DNA sequencing. Illumina, Inc. filed that petition, and two others, IPR2012-00007 and IPR2013-00011, against patents owned by The Trustees of Columbia University in the City of New York ("Columbia"). The PTAB issued its Final Written Decisions…
-
The ABA Journal has begun work on its 9th annual list of the 100 best legal blogs (or blawgs) and has announced that it is seeking the advice of its readers, via the ABAJournal.com website, on which blogs to include on this year's Blawg 100. For the past three years, Patent Docs has been honored…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Millennium Pharmaceuticals Inc. v. Dr. Reddys Laboratories, Ltd. et al.1:15-cv-00539; filed June 25, 2015 in the District Court of Delaware • Plaintiff: Millennium Pharmaceuticals Inc.• Defendants: Dr. Reddys Laboratories, Ltd.; Dr. Reddys Laboratories, Inc.…
-
August 6, 2015 – "Maximizing Patent Prosecution Opportunities in Europe: Tactics for Counsel When Drafting U.S.-Origin Applications — Navigating Differing USPTO and EPO Legal Standards While Maintaining U.S. Patent Strategy" (Strafford) – 1:00 to 2:30 pm (EDT) August 10-11, 2015 – "Advanced Patent Prosecution Seminar 2015: Claim Drafting & Amendment Writing" (Practising Law Institute) –…
-
The American Intellectual Property Law Association (AIPLA) and U.S. Patent and Trademark Office will be co-hosting a series of cross-country roadshows in August in Santa Clara, CA (August 24); Dallas, TX (August 26); and Alexandria, VA (August 28). The Santa Clara roadshow is being co-sponsored by the High Tech Law Institute of Santa Clara Law and the…
-
Practising Law Institute (PLI) will be holding a seminar on Developments in Pharmaceutical and Biotech Patent Law 2015 on September 18, 2015 in San Francisco, CA and on October 2, 2015 in New York, NY. The San Francisco session will also be offered as a webcast. Topics to be covered at the seminar include: •…
-
The American Intellectual Property Law Association (AIPLA) will be offering a webinar on "Biosimilars: Regulation, Litigation and New Developments Patent Practitioners and Regulatory Attorneys Should Know" on August 27, 2015 from 12:30 – 2:00 pm (Eastern). Debora Plehn-Dujowich of Prismatic Law Group, PLLC, James C. Shehan of Hyman Phelps & McNamara, and Sanya Sukduang of…
Patent Docs 